25-Feb-2015 - Max-Planck-Institut für Kolloid- und Grenzflächenforschung

An assembly line for medications

Efavirenz can now be produced more cost efficiently and sustainable utilizing continuous flow chemistry.

Researchers at the Max Planck Institute of Colloids and Interfaces (MPICI) and the Freie Universität Berlin have succeeded in developing better methods of producing APIs (active pharmaceutical ingredients). As a result, Efavirenz, one of the preferred agents for treating HIV in combination therapies, can now be produced using a concise continuous flow method. This process may fundamentally change the way APIs are produced.

Today, virtually all active pharmaceutical ingredients (APIs) are produced using multiple distinct processes in “batch”. This means that all ingredients react in a pot, pretty similar to the method of cooking. “Continuous flow” means the reaction takes places while the chemicals move through a “pipe” or some tubing – conceptually similar to a conveyer belt. In this way, the reactions are safer and more efficient.

Flow chemistry has fundamental advantages when compared to other methods. The target product can be produced in a faster, more cost efficient manner and, more often than not, with better product quality. The smaller amounts of chemicals reacting in flow devices don´t lead to smaller production charges. In principle this can be compared with a bucket under a dripping faucet. The bucket can be filled opening the faucet (fast), but over time constant dripping (slow) will lead to the same effect. In reality, the total time consumption leading to a similar amount of API is comparable, but in flow the reaction needs less investment and exhibits a much higher degree of control.

In addition to producing single medications such as Efavirenz continuously, a single, modular reactor can be used to produce patented and generic medicines such as lyrica, gabapentin, and baclofen – used to treat general anxiety disorder, epilepsy, and spasticity, respectively. The total value of the medications sold each year exceeds five billion Euros. These medications belonging to three different structural classes (g-amino acids, g-lactams and β-amino acids) were produced by just changing the order of reactors.

Most commodity products, including cars, are produced by using assembly lines. The Max Planck researchers demonstrate for the first time that a modular assembly line system for the production of important medications can work. Prof. Dr. Peter H. Seeberger emphasizes: “Our modular flow technology will fundamentally change the way APIs are produced. We have demonstrated that the conceptual breakthrough now yields better access to life saving drug substances such as the HIV medication Efavirenz. In a next step these processes will have to be industrialized.”

Dr. Kerry Gilmore, group leader of the “flow chemistry” team adds: “What is truly revolutionary about this approach is not the incremental advance in reactor technology, but the conceptual leap of synthesizing a range of products using a single modular setup, allowing access to multiple medicines without the need for multiple production facilities.”

For the key step of the synthesis of Efavirenz a readily available and harmless copper catalyst was used, substituting toxic chemicals such as phosgene, a chemical warfare agent.

Dr. Camille Correia, from the South American country of Guyana, the key chemist in the synthesis of the HIV medication, hopes the effort of the team will have an impact: “We were able to produce the medication in three chemical steps in less than two hours. To the best of our knowledge this is the most cost efficient and fastest method available. Unfortunately Efavirenz is often too expensive for patients in developing countries. We hope our effort helps to lower the market price for life saving drugs.”

Facts, background information, dossiers
  • MPI für Kolloid- un…
  • Freie Universität Berlin
  • active pharmaceutic…
More about MPI für Kolloid- und Grenzflächenforschung
  • News

    Largest Synthetic Polysaccharide Assembled

    Chemists at the Max Planck Institute of Colloids and Interfaces (Potsdam, Germany) have set a milestone by preparing the two largest carbohydrates ever assembled. Using an Automated Glycan Assembly (AGA) instrument originally developed at the institute they prepared a linear 100-mer and ach ... more

    A chemical factory for all cases

    In the future, bottlenecks in the supply of medicines could be more easily eliminated. An automated machine for radial synthesis developed by chemists at the Max Planck Institute of Colloids and Interfaces will enable the flexible production of medical agents and other chemical products. Th ... more

    New material for chemistry text books

    Even the well-known can sometimes surprise. Calcium carbonate (CaCO3), also known colloquially as lime or chalk, is a mineral that has already been thoroughly analysed by chemists. But chemistry books, in which it is listed as occurring in five different crystal structures, now need to be a ... more

More about Max-Planck-Gesellschaft
  • News

    Environmentally friendly production of mandelic acid

    Sometimes potentially useful enzymes are not easy to discover because their biocatalytic capabilities may go beyond their natural and thus known range of action. By recombining a newly discovered enzymatic capability, a research team from the Max Planck Institute for Terrestrial Microbiolog ... more

    The Higgs boson and superconductivity

    Without the Higgs mechanism, particles would have no mass. The Higgs boson, which was discovered in 2012, is therefore also referred to as the “God particle”. It arises as an oscillating excitation of the Higgs field, which penetrates the world. Superconductivity displays similar properties ... more

    Weighing an ant on top of an elephant: Quantum jump tipping the balance

    A new door to the quantum world: when an atom absorbs or releases energy via the quantum jump of an electron, it becomes heavier or lighter, according to Einstein’s theory of relativity (E = mc²). However, the effect is minuscule for a single atom. Nevertheless, the team of Klaus Blaum and ... more

More about Freie Universität Berlin
  • News

    Attosecond Electron Catapult

    A team of physicists and chemists from the University of Rostock, the Laboratory of Attosecond Physics at the Ludwig-Maximilians-Universität, the Max Planck Institute of Quantum Optics, and Freie Universität Berlin has studied the interaction of light with tiny glass particles. The relation ... more

    Good Quantum States and Bad Quantum States

    A theoretical trick allows scientists to describe quantum states of thousands of atoms. If standard methods were used, all storage capacity in the world would not be enough to do this. For a long time, quantum experiments were only carried out with a small number of particles. Even the beha ... more

    Investigating micelles, as easy as ABC

    German scientists have used cryogenic transmission electron microscopy to investigate the fluorinated domains within ABC triblock copolymer micelles. Christoph Böttcher from Freie Universität Berlin, André Laschewsky from Universität Potsdam, and their colleagues, have shown using cryo-tran ... more